Navigation Links
With Prostate Cancer: Waiting for Symptoms Is Not an Option
Date:7/1/2008

NEW YORK, July 1 /PRNewswire/ -- Prostate cancer is the second leading cause of death among American males, but when caught early, prostate cancer has a 90% cure rate.

According to Dr. David Samadi, Chief, Division of Robotics and Minimally Invasive Surgery, Department of Urology, at Mount Sinai Medical Center, "The key to fighting prostate cancer is not to wait until there are warning signs, because by then it may be too late."

The tendency of prostate cancer to grow without causing noticeable symptoms leads doctors to recommend that men over 50 get screened every year. However, Dr. Samadi recommends that anyone with a strong family history of the disease or other risk factors get screened at age 40.

Routine screening for prostate cancer consists of a PSA (prostate-specific antigen) blood test and a digital rectal exam. Most doctors regard a PSA score of less than 4.0 as normal, however, Dr. Samadi regards a jump in PSA velocity to be a warning sign. For example, an increase in the PSA velocity from 0.8 one year to 1.6 the following may be a red flag requiring a biopsy to test for cancer cells. If there is need for treatment, there are surgical options for removal of the prostate with varying outcomes that can dramatically impact the recovery process and quality of life.

"The most common treatment for prostate cancer is surgical removal of the prostate or prostatectomy traditionally done by open surgery," Dr. Samadi says. "While results of open surgery are generally excellent, there are distinct downsides. For one thing, the surgeon makes an 8- to 10-inch incision to remove a 2-inch organ, which causes enough blood loss that about 20 percent of patients require a blood transfusion. That large incision also means more pain and a higher risk of infection."

Robotic prostate surgery is virtually "bloodless" and involves five small "keyhole" incisions in the patient's abdomen, through which fine instruments are inserted, along with a miniscule camera that displays magnified images from inside the body. The robotic control system enables the surgeon's hand movements to be more precise, resulting in less trauma to surrounding tissue, and minimal blood loss. Men who opt for robotic laparoscopic surgery are cancer free and able to resume normal lifestyles with total control over their sexual functions and bladder. Cancer free outcomes also result from traditional open prostate surgery, but men are rendered impotent and incontinent -- both of which may never be reversed. These side effects are devastating to prostate cancer patients, and have led to failed marriages and relationships, and depression.

Instead of two to three days of hospitalization and two months of recuperation typical with open surgery, robotic surgery patients go home the next day and are back to normal activities within two weeks. These patients have an excellent chance of being cancer-free with great quality of life. For more information, call 212-241-8779 or log on to http://www.roboticoncology.com.

Media Contact: Cathy Callegari -- 212-579-1370 or cathy@callprinc.com


'/>"/>
SOURCE Dr. David Samadi, Mount Sinai Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 2016 , ... An April Gallup survey found rising health care costs to ... Sun Health Senior Living (SHSL) may not share those same worries thanks to ... for the year, while holding the line on increasing their contributions, including premiums, deductibles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science ... the organization has earned its ISO 13485 certification, indicating the company’s quality control ... rules and policies associated with ISO quality standard 13485. , BSI Group ...
(Date:5/26/2016)... Texas (PRWEB) , ... May 26, 2016 , ... ... Friday, May 13 at Blackhorse Golf Club in Cypress. With the help of community ... non-profit that restores, empowers, and renews hope for wounded service members and their families ...
(Date:5/26/2016)... ... May 26, 2016 , ... The MIAMI Institute for Age Management and ... Adonis Maiquez MD, ABAARM. Dr. Adonis , Wellness Physician of the MIAMI Institute ... of the Institute for Functional Medicine. , He also heads up FITTLab, the comprehensive ...
(Date:5/26/2016)... ... ... Bunion Bootie , the manufacturer of the newest and best in ... customer demand over the Mother’s Day Weekend promotion. So much so, that they completely ... completely replenished its inventory levels, it hopes to continue its current sales pace, and ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
(Date:5/24/2016)... 2016  Diana Russell suffers from a form of ... inside out.  This disease has put her in a ... and grandchildren to leave her home.  Because of the ... haul the wheelchair.  So if there is a family ... is left to wait for the bus. ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
Breaking Medicine Technology: